You'll See More "Concomitant" Quadruple Therapy for H. pylori

March 2017

You'll see changes in preferred drug regimens for H. pylori.

Triple therapy with a PPI and two antibiotics (Prevpac, etc) will fall out of favor. It's not as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.

Expect to see a shift based on new guidelines...with more use of QUADRUPLE therapy and treating for 14 days instead of 7 to 10 days.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Gastroenterology You'll See More "Concomitant" Quadruple Therapy for H. pylori
Insulin Explain How Different Insulins Compare
Travel Medicine Help Patients Prepare for Travel-Related Illnesses
Allergic Reactions Evaluate if Patients Are Really Allergic to Penicillin
Women's Health Continue to Avoid ACE Inhibitors in Women Who May Become Pregnant
Iron Recommend Ferrous Sulfate or Ferrous Fumarate When Oral Iron Is Needed
Cardiology Avoid QT-Prolonging Meds in High-Risk Patients
Asthma Help Ensure Asthma Patients Have the Right Exacerbation Meds On Hand
Cholesterol Stay Tuned to the LDL Controversy
Pulmonary What to Expect With Meds for Pulmonary Arterial Hypertension
Ear Health Explain It's Usually Better to Leave Earwax Alone
Medication Errors Be Cautious With Drug Names That End in the Letter "L"
Practice You'll soon see a new and improved website for Pharmacist's Letter

You'll See More "Concomitant" Quadruple Therapy for H. pylori

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents